[go: up one dir, main page]

ES2187038T3 - Glicosidos modificados, composiciones que los comprenden y procedimientos para su utilizacion. - Google Patents

Glicosidos modificados, composiciones que los comprenden y procedimientos para su utilizacion.

Info

Publication number
ES2187038T3
ES2187038T3 ES98932361T ES98932361T ES2187038T3 ES 2187038 T3 ES2187038 T3 ES 2187038T3 ES 98932361 T ES98932361 T ES 98932361T ES 98932361 T ES98932361 T ES 98932361T ES 2187038 T3 ES2187038 T3 ES 2187038T3
Authority
ES
Spain
Prior art keywords
modified
variety
glycosids
procedures
understand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98932361T
Other languages
English (en)
Inventor
Camilo Colaco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quadrant Drug Delivery Ltd
Original Assignee
Elan Drug Delivery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Drug Delivery Ltd filed Critical Elan Drug Delivery Ltd
Application granted granted Critical
Publication of ES2187038T3 publication Critical patent/ES2187038T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Se proporcionan glucósidos modificados que pueden utilizarse para formar una variedad de materiales, incluyendo sistemas de administración sólida, y dispositivos o recubrimientos coloreados ópticamente transparentes. Los sistemas de administración sólida pueden utilizarse para la administración y la liberación de una variedad de sustancias que pueden estar en forma de comprimidos para administración oral o en forma de polvos, microesferas o implantes para por vía intravenosa, intradérmica, transdérmica, pulmonar u otra vía de administración. Los glucósidos modificados pueden procesarse para formar una matriz de vidrio vítreo con una sustancia, tal como un agente terapéutico, o un tinte ópticamente activo incorporado a la misma. En una realización, la matriz de vidrio vítreo se proporciona en una forma de dosificación sólida que es capaz de liberar una sustancia terapéutica in situ a diversas velocidades controladas.
ES98932361T 1997-07-03 1998-07-03 Glicosidos modificados, composiciones que los comprenden y procedimientos para su utilizacion. Expired - Lifetime ES2187038T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5172797P 1997-07-03 1997-07-03

Publications (1)

Publication Number Publication Date
ES2187038T3 true ES2187038T3 (es) 2003-05-16

Family

ID=21973024

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98932361T Expired - Lifetime ES2187038T3 (es) 1997-07-03 1998-07-03 Glicosidos modificados, composiciones que los comprenden y procedimientos para su utilizacion.

Country Status (9)

Country Link
EP (1) EP0994887B1 (es)
JP (1) JP2002510316A (es)
AT (1) ATE228528T1 (es)
AU (1) AU8229998A (es)
DE (1) DE69809746T2 (es)
DK (1) DK0994887T3 (es)
ES (1) ES2187038T3 (es)
PT (1) PT994887E (es)
WO (1) WO1999001463A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586006B2 (en) * 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
US6352722B1 (en) 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
GB9916316D0 (en) 1999-07-12 1999-09-15 Quadrant Holdings Cambridge Dry powder compositions
CN1431919A (zh) 2000-04-03 2003-07-23 巴特勒记忆研究所 装置和制剂
GB0017999D0 (en) 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
JP2004526674A (ja) 2000-12-01 2004-09-02 バテル・メモリアル・インスティテュート 液体処方物中における生体分子の安定化のための方法
EP1752189A3 (en) * 2001-04-20 2007-02-21 Alza Corporation Microprojection array having a beneficial agent containing coating
GB0208608D0 (en) * 2002-04-13 2002-05-22 Glaxo Group Ltd Composition
GB0208609D0 (en) * 2002-04-13 2002-05-22 Glaxo Group Ltd Compositions
EP1428526A1 (en) * 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Formulation for fast dissolution of lipophilic compounds
JP4722386B2 (ja) * 2003-08-22 2011-07-13 広島県 糖脂質及びその製造方法
WO2006014930A2 (en) * 2004-07-26 2006-02-09 Cotherix, Inc. Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
WO2007013160A1 (ja) 2005-07-28 2007-02-01 Saga University ラジカル滅菌装置
WO2023077447A1 (zh) * 2021-11-05 2023-05-11 中国科学院过程工程研究所 环肽玻璃及含有环肽的药物组合物玻璃
CN114014908B (zh) * 2021-11-05 2023-08-22 中国科学院过程工程研究所 环肽玻璃及含有环肽的药物组合物玻璃

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ297431B6 (cs) * 1994-08-04 2006-12-13 Quadrant Holdings Cambridge Limited Prostredek obsahující dodávací systém pevné dávkypro prímou aplikaci v pevné forme a zpusob jeho výroby

Also Published As

Publication number Publication date
DE69809746T2 (de) 2004-09-30
EP0994887A2 (en) 2000-04-26
DE69809746D1 (de) 2003-01-09
EP0994887B1 (en) 2002-11-27
JP2002510316A (ja) 2002-04-02
DK0994887T3 (da) 2003-03-17
ATE228528T1 (de) 2002-12-15
WO1999001463A3 (en) 1999-03-25
PT994887E (pt) 2003-04-30
WO1999001463A2 (en) 1999-01-14
AU8229998A (en) 1999-01-25

Similar Documents

Publication Publication Date Title
ES2187038T3 (es) Glicosidos modificados, composiciones que los comprenden y procedimientos para su utilizacion.
ATE235503T1 (de) Kohlenhydraten verwendbar in feste verabreichungssysteme
AR002754A1 (es) Composición farmacéutica que comprende bacterias lactobacillus viables micro-encapsuladas, y uso de la composición para preparar de un medicamento
AU7465087A (en) Controlled release bioerodible drug delivery system
DK1077727T3 (da) Sammensætning til adhæsiv mikrosfærelægemiddelafgivelse
EP2266542A3 (en) Controlled release nanoparticulate compositions
AR027091A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
DK0663820T3 (da) Farmaceutisk tablet, som er i stand til at frigive ét eller flere lægemidler med forskellige frigivelseshastigheder
PA8575701A1 (es) Preparaciones acidas de insulina con estabilidad mejorada
BR0112054A (pt) Composição formadora de micelas, e métodos para a administração e a proteção de um agente terapêutico
MX9200180A (es) DERIVADOS DE LA 5H-PIRROL (3,4-b) PIRAZINA OPTICAMENTE ACTIVOS, PROCEDIMIENTO PARA SU PREPARACION Y COMPOSICION FARMACEUTICA QUE LOS CONTIENE.
PE71699A1 (es) Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra
ATE84032T1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ES2059495T3 (es) Dispositivo de descarga de farmacos regulado por solubilidad.
BR9814751A (pt) Composição sólida seca para liberação de droga, processo para a preparação da mesma, e, uso de um grande número de partìculas porosas inorgânicas que são compostas de hidroxiapatita de cerâmica.
PE17897A1 (es) Formulacion transdermica en parche del 3-(4-butiltio)-1,2,5-tiadiazol-3-il)-1-azabiciclo (2,2,2) octano
ES2060708T3 (es) Sistema terapeutico de liberacion retardada para formulaciones farmaceuticas liquidas.
ES2173453T3 (es) Nuevos dispositivos destinados a la administracion transdermica de trimegestona.
DK1144420T3 (da) Sulfaterede phosphatidylinositoler, fremgangsmåde til fremstilling heraf og anvendelser heraf
ES2164764T3 (es) Excipiente de liberacion sostenida.
ES2043567T1 (es) Una composicion farmaceutica de liberacion controlada para uso oral que contiene farmacos anti-inflamatorios no esteroideos.
ES2127305T3 (es) Una forma farmaceutica para la administracion rectal de compuestos farmacologicamente activos.
ES2052245T3 (es) Procedimiento de dispersion de las tensiones durante una operacion de formacion de tabletas.
ECSP024290A (es) Composiciones farmacéuticas y uso de las mismas